» Articles » PMID: 21300969

Sun Exposure and Vitamin D Are Independent Risk Factors for CNS Demyelination

Overview
Journal Neurology
Specialty Neurology
Date 2011 Feb 9
PMID 21300969
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To examine whether past and recent sun exposure and vitamin D status (serum 25-hydroxyvitamin D [25(OH)D] levels) are associated with risk of first demyelinating events (FDEs) and to evaluate the contribution of these factors to the latitudinal gradient in FDE incidence in Australia.

Methods: This was a multicenter incident case-control study. Cases (n = 216) were aged 18-59 years with a FDE and resident within one of 4 Australian centers (from latitudes 27°S to 43°S), from November 1, 2003, to December 31, 2006. Controls (n = 395) were matched to cases on age, sex, and study region, without CNS demyelination. Exposures measured included self-reported sun exposure by life stage, objective measures of skin phenotype and actinic damage, and vitamin D status.

Results: Higher levels of past, recent, and accumulated leisure-time sun exposure were each associated with reduced risk of FDE, e.g., accumulated leisure-time sun exposure (age 6 years to current), adjusted odds ratio (AOR) = 0.70 (95% confidence interval [CI] 0.53-0.94) for each ultraviolet (UV) dose increment of 1,000 kJ/m(2) (range 508-6,397 kJ/m(2)). Higher actinic skin damage (AOR = 0.39 [95% CI 0.17-0.92], highest grade vs the lowest) and higher serum vitamin D status (AOR = 0.93 [95% CI 0.86-1.00] per 10 nmol/L increase in 25(OH)D) were independently associated with decreased FDE risk. Differences in leisure-time sun exposure, serum 25(OH)D level, and skin type additively accounted for a 32.4% increase in FDE incidence from the low to high latitude regions.

Conclusions: Sun exposure and vitamin D status may have independent roles in the risk of CNS demyelination. Both will need to be evaluated in clinical trials for multiple sclerosis prevention.

Citing Articles

Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosis.

Al-Shammri S, Chattopadhyay A, Mustafa A Front Neurol. 2025; 16:1455779.

PMID: 39990260 PMC: 11842254. DOI: 10.3389/fneur.2025.1455779.


Association Between Sun Exposure and Risk of Relapse in Pediatric-Onset Multiple Sclerosis.

Chang G, Sebastian P, Virupakshaiah A, Schoeps V, Cherbuin N, Casper T Neurol Neuroimmunol Neuroinflamm. 2025; 12(2):e200375.

PMID: 39938013 PMC: 11820808. DOI: 10.1212/NXI.0000000000200375.


Assessment of vitamin D status and associated risk factors in high-altitude populations affected by multiple sclerosis: A case-control study.

Alelyani M, Gameraddin M, Alshahrani R, Alaslami W, Sarhan R, Alghamdi S Medicine (Baltimore). 2024; 103(22):e38369.

PMID: 39259102 PMC: 11142836. DOI: 10.1097/MD.0000000000038369.


Multiple sclerosis and abnormal spermatozoa: A bidirectional two-sample mendelian randomization study.

Li B, Zhang L, Li Q, Zhang J, Wang W, Quan J PLoS One. 2024; 19(8):e0308815.

PMID: 39163298 PMC: 11335101. DOI: 10.1371/journal.pone.0308815.


Causal associations between 25-hydroxyvitamin D levels and NMOSD: a two-Sample Mendelian randomization analysis.

Zhu Y, Zhou X, Jia J, Xue Q Neurol Sci. 2024; 45(5):2379-2381.

PMID: 38175315 DOI: 10.1007/s10072-023-07290-x.